DRKS00034405尚未招募不适用
Blood Donor and Recipient Long-Term Outcome Study - LOS
Goethe Universität Frankfurt, Universitätsklinikum, Klinik für Anästhesiologie, Intensivmedizin und Schmerztherapie0 个研究点目标入组 1,000,000 人开始时间: 2024年7月10日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- 入组人数
- 1,000,000
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- one 至 one（—）
- 性别
- All
入选标准
- •? All individuals voluntarily donating blood, which includes the donation of red blood cells, thrombocytes, plasma, cryoplasma, and coagulation factors
- •? All persons who receive blood products, i.e. outpatients and inpatients who receive any quantity and type of blood products derived from human blood donors (red blood cells, platelets, plasma, cryoplasma, and coagulation factors of human origin and/or medication impacting in any way on the bone marrow (e.g. erythropoietin, iron formulations, platelet-releasing drugs, and other)
- •? All donors/recipients willing to give their informed consent for the study
- •? Any individuals that cannot give their consent can be included if someone has been granted medical power of attorney, and can consent for them
- •? Participants under 18 years can be included if their legal guardian(s) give(s) consent
- •? The coverage of the LOS Registry includes participants donating or receiving a single blood product or more and/or coagulation factors of human origin or medication impacting in any way on the bone marrow
- •? Registration can take place at any point in the treatment process, but must ensure that all diagnosed adverse events are recorded
排除标准
- 未提供
研究者
相似试验
未知
不适用
A prospective cohort study of blood transfusion-dependent chronic anemia in AkitaChronic anemia dependent on red cell transfusionJPRN-UMIN000001908Akita University School of Medicine, Department of Medicine, Division of Hematology, Nephrology and Rheumatology100
终止
不适用
Blood Donation--Immune Sequelae and RecruitmentBlood DonorsBlood DiseaseNCT00005341University of New Mexico
已完成
不适用
Prospective study to examine whether Blood N-terminal proBNP (N-terminal pro brain natriuretic peptide) can be used as an indicator of cardiac preload during massive fluid resuscitation in critically ill patients.JPRN-UMIN000004671Emergency Medicine60
已完成
不适用
Short-term and long-term outcomes in living donors for liver transplantatioliving donors for liver transplantationJPRN-UMIN000041155Okayama University Hospital408
已完成
不适用
Randomised trial of a blood transfusion policy after fracture of the proximal femur (hip fracture)Surgery: Blood transfusionSurgeryBlood transfusionISRCTN61328173Department of Health (UK)